Tenascin-C is upregulated in the skin lesions of patients with atopic dermatitis
- 1 October 2005
- journal article
- Published by Elsevier in Journal of Dermatological Science
- Vol. 40 (1) , 35-41
- https://doi.org/10.1016/j.jdermsci.2005.06.001
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Gene expression of enzymes for tryptophan degradation pathway is upregulated in the skin lesions of patients with atopic dermatitis or psoriasisJournal of Dermatological Science, 2004
- Tenascins: regulation and putative functions during pathological stressThe Journal of Pathology, 2003
- Effect of Tenascin-C Deficiency on Chemically Induced Dermatitis in the MouseJournal of Investigative Dermatology, 1998
- Tenascin Suppresses CD3-Mediated T Cell ActivationBiochemical and Biophysical Research Communications, 1998
- Tenascin-C is not a Useful Marker for Disease Activity in PsoriasisActa Dermato-Venereologica, 1998
- Advances in quantitative PCR technology: 5′ nuclease assaysCurrent Opinion in Biotechnology, 1998
- IL-4 Upregulates Tenascin Synthesis in Scleroderma and Healthy Skin FibroblastsJournal of Investigative Dermatology, 1996
- The Human Integrin α8β1 Functions as a Receptor for Tenascin, Fibronectin, and VitronectinPublished by Elsevier ,1995
- The Cytokine Network in Lesional and Lesion-Free Psoriatic Skin Is Characterized by a T-Helper Type 1 Cell-Mediated ResponseJournal of Investigative Dermatology, 1993
- Tenascin expression in hyperproliferative skin diseasesBritish Journal of Dermatology, 1991